Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Oktober 2022 04:10 ET | Quelle: Vantage Market Research

Multiple Sclerosis (MS) Drugs Market Size to Hit Sales of $31.2 Bn by 2028 | Biogen, Novartis, and Roche Hold Over 55% Share of Multiple Sclerosis Drugs

WASHINGTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Global multiple sclerosis drugs market size was $25.1 Billion in 2021 and is estimated to generate revenue of $31.2 Billion by 2028 at a CAGR of 3.7%...
26. April 2022 05:50 ET | Quelle: Fortune Business Insights

With 6.3% CAGR, Multiple Sclerosis Drugs Market Size Worth USD 41.99 Billion in 2028

Pune, India, April 26, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
21. Dezember 2021 09:30 ET | Quelle: Visiongain Ltd

Multiple Sclerosis Drugs Market Report Up to 2031: Visiongain Research Inc

Visiongain has published a new report on Multiple Sclerosis Drugs Market Report 2021-2031:Forecasts By Drug Class (Corticosteroids, Interferon Beta, Sphingosine 1 Phosphate Receptor Modulators, Mixed...
29. April 2021 07:03 ET | Quelle: Fortune Business Insights

Multiple Sclerosis Drugs Market Size 2021 | Is Projected to Reach USD 40.66 Billion by 2027, Exhibiting a CAGR of 7.1% during 2020-2027

Pune, India, April 29, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period....